Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Assets (2014 - 2026)

Mesoblast (MESO) posted Assets of $782.3 million for Q4 2025, little changed sequentially from $784.7 million in Q2 2025, and up 19.74% YoY from $653.3 million in Q4 2024.

Analysis

Mesoblast (MESO) Assets (2014 - 2026) Analysis & Trends

Mesoblast has reported Assets for 11 years, with the latest figure at $782.3 million in Q4 2025.

  • Quarterly Assets rose 19.74% year-over-year to $782.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $782.3 million (up 19.74% YoY) and the FY2025 annual result came in at $784.7 million, up 17.27% from the prior year.
  • Assets was little changed at $782.3 million in Q4 2025 per MESO's latest filing, from $784.7 million in the prior quarter.
  • Over five years, Assets peaked at $784.7 million in Q2 2025 and troughed at $650.4 million in Q1 2023.
  • A 5-year average of $700.9 million and a median of $681.7 million in 2022 frame the typical range for Assets.
  • The sharpest annual moves came in 2022 and 2025: Assets fell 11.09% in 2022, then advanced 19.74% in 2025.
  • Over 5 years, Assets stood at $704.4 million in 2021, then declined by 5.16% to $668.1 million in 2022, then gained by 0.33% to $670.3 million in 2023, then declined by 2.53% to $653.3 million in 2024, then increased by 19.74% to $782.3 million in 2025.
  • According to Business Quant data, Assets over the past three periods registered $782.3 million, $784.7 million, and $653.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 10.96 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.32 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 9.18 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.56 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.10 Bn
10 Mesoblast 2.24 Bn 2.14 Bn - 773.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 773.08 Mn
Dec 31, 2025 782.31 Mn
Jun 30, 2025 784.68 Mn
Dec 31, 2024 653.32 Mn
Jun 30, 2024 669.15 Mn
Dec 31, 2023 670.29 Mn
Jun 30, 2023 669.42 Mn
Mar 31, 2023 650.44 Mn
Dec 31, 2022 668.06 Mn
Sep 30, 2022 684.50 Mn
Jun 30, 2022 662.14 Mn
Mar 31, 2022 681.69 Mn
Dec 31, 2021 704.44 Mn
Sep 30, 2021 721.82 Mn
Jun 30, 2021 744.72 Mn
Mar 31, 2021 766.13 Mn
Dec 31, 2020 687.31 Mn
Sep 30, 2020 712.57 Mn
Jun 30, 2020 733.60 Mn
Mar 31, 2020 665.79 Mn